PHAR 502 Midterm Exam Questions with correct Answers 2025/2026( A+ GRADED 100% VERIFIED).

PHAR 502 Midterm
Caution for use of SFU - ANS-- elderly
- alcoholics

Glipizide usual dose - ANS-10 mg ii PO BID

Glyburide max dose - ANS-20 mg/day

Glimepiride - ANS-- Comes in 1, 2, & 4 mg
- Does not come in 5 mg

Glipizide - ANS-- SFU
- Glucotrol (XL)
- 5 & 10 mg

Glyburide - ANS-- SFU
- DiaBeta
- 1.25, 2.5, & 5 mg

Glimepiride - ANS-- SFU
- Amaryl
- 1, 2, & 4 mg

Meglitinides - ANS-- stimulates insulin secretion fr B cells of pancreas
- Mainly used for PPG reduction
- Repaglinide
- Nateglinide

Repaglinide - ANS-- Meglitinide
- Prandin
- 0.5, 1, & 2 mg

Nateglinide - ANS-- Meglitinide
- Starlix
- 60 & 120 mg

Thiazolidinediones "Glitazones" - ANS-- increase insulin sensitivity
- Pioglitazone
- Rosiglitazone

, Pioglitazone - ANS-- TZD
- Actos
- 15, 30, & 45 mg

Rosiglitazone - ANS-- TZD
- Avandia
- 2, 4 & 8 mg

Diagnosis of Diabetes
FPG - ANS->/= 126 mg/dL

Diagnosis of Diabetes
2 -hr PG - ANS-> / = 200 mg/dL

Diagnosis of Diabetes
A1C - ANS->/ = 6.5%

Diabetes - ANS-- A1C >/= 6.5%
- FPG >/= 126
- random >/= 200

Pre-diabetes - ANS-- A1C = 5.7-6.4%
- FPG = 100 -125
- random = 140 - 199

Normal - ANS-- A1C < 5.7%
- FPG = 70 - 99
- random < 140

Rapid Acting Analogs - ANS-- Rx Only
- Onset ~15 min
- Peak 1 hr
- Duration 3-5 hrs
- Lispro, Aspart, & Glulisine

Lispro - ANS-- Rapid Acting
- Humalog & Admelog

Aspart - ANS-- Rapid Acting
- Novolog, Fiasp, & Lyumjev

Glulisine - ANS-- Rapid Acting
- Apidra